Acrivon Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.93 | $-1.08 |
| FY2022 | $-1.51 | $-1.35 |
| FY2023 | $-2.74 | $-1.84 |
| FY2024 | $-2.38 | $-1.98 |
| FY2025 | $-2.02 | $-1.98 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.93 | $-1.08 |
| FY2022 | $-1.51 | $-1.35 |
| FY2023 | $-2.74 | $-1.84 |
| FY2024 | $-2.38 | $-1.98 |
| FY2025 | $-2.02 | $-1.98 |